New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Humana Inc.
HUM
Shape
US Flag

NYSE

31B

Medical - Healthcare Plans

Next Earning date - 30 Oct 2024

31B

Medical - Healthcare Plans

Next Earning date - 30 Oct 2024

260.73USD
Shape2.15 ( 0.83%)
favorite-chart

Relative Strenght

12
favorite-chart

Volume Buzz

-13%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

51%

Quote Panel

Shape
Updated October 27, 2024
1W 0.06 % 1M -17.68 % 3M -33.32 % 1Y -49.17 %

Key Metrics

Shape
  • Market Cap

    31.39B


  • Shares Outstanding

    120.40M


  • Share in Float

    120.10M


  • Dividende

    3.54


  • Earning Date

    30 Oct 2024


  • Price Target

    260.73


  • Average Volume

    2.10M


  • Beta

    0.503


  • Range

    213.31-527.18


  • Industry

    Medical - Healthcare Plans


  • Website

    https://www.humana.com


  • Sector

    Healthcare


Fundamentals

Shape

11.93x

P/E Ratio

0.28x

P/S Ratio

1.88x

P/B Ratio

0.8

Debt/Equity

1.5%

Net Margin

$14.2

EPS

How HUM compares to sector?

P/E Ratio

Relative Strength

Shape

HUM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$117B

Shape295%

2025-Revenue

$18.85

Shape234%

2025-EPS

$7B

Shape2277%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

KeyBanc

initialise

Previous: Not converted

2024-10-10

Now: Sector Weight

Bernstein

upgrade

Previous: Market Perform

2024-10-08

Now: Outperform

Zacks Investment Research

downgrade

Previous: Not converted

2024-10-07

Now: Negative

Cowen & Co.

downgrade

Previous: Buy

2024-10-07

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+42%

6.88
vs 4.83

Q4.22

arrow
arrow

+31%

1.62
vs 1.24

Q1.23

arrow
arrow

+17%

9.38
vs 8.04

Q2.23

arrow
arrow

+3%

8.94
vs 8.67

Q3.23

arrow
arrow

+13%

7.78
vs 6.88

Q4.23

arrow
arrow

N/A

-0.11
vs 1.62

Q1.24

arrow
arrow

-23%

7.23
vs 9.38

Q2.24

arrow
arrow

-22%

6.96
vs 8.94

Q3.24

arrow
arrow

-57%

3.38
vs 7.78

Q4.24

arrow
arrow

N/A

-1.34
vs -0.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+4%

22.8B  vs 21.8B

Q4.22

arrow
arrow

+7%

22.4B  vs 21.1B

Q1.23

arrow
arrow

+12%

26.7B  vs 24B

Q2.23

arrow
arrow

+13%

26.7B  vs 23.7B

Q3.23

arrow
arrow

+16%

26.4B  vs 22.8B

Q4.23

arrow
arrow

+18%

26.5B  vs 22.4B

Q1.24

arrow
arrow

+11%

29.6B  vs 26.7B

Q2.24

arrow
arrow

+10%

29.5B  vs 26.7B

Q3.24

arrow
arrow

+9%

28.7B  vs 26.4B

Q4.24

arrow
arrow

+8%

28.7B  vs 26.5B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+7%

0.07
vs 0.04

Q4.22

arrow
arrow

0%

-0.00
vs 0.07

Q1.23

arrow
arrow

+7%

0.07
vs -0.00

Q2.23

arrow
arrow

+6%

0.06
vs 0.07

Q3.23

arrow
arrow

+5%

0.05
vs 0.06

Q4.23

arrow
arrow

-3%

-0.03
vs 0.05

Q1.24

arrow
arrow

+5%

0.05
vs -0.03

Q2.24

arrow
arrow

+4%

0.04
vs 0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

1034

1K
vs 990

4%

Q4.22

arrow
arrow

1123

1.1K
vs 1K

9%

Q1.23

arrow
arrow

1088

1.1K
vs 1.1K

-3%

Q2.23

arrow
arrow

1110

1.1K
vs 1.1K

2%

Q3.23

arrow
arrow

1133

1.1K
vs 1.1K

2%

Q4.23

arrow
arrow

1207

1.2K
vs 1.1K

7%

Q1.24

arrow
arrow

1087

1.1K
vs 1.2K

-10%

Q2.24

arrow
arrow

1015

1K
vs 1.1K

-7%

Earnings Growth

Latest News